Similar articles

• Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.

  Brestel EP. Brestel EP. Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00020. Ann Intern Med. 2000. PMID: 10979887 No abstract available.
• Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.

  Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS. Edelman JM, et al. Ann Intern Med. 2000 Jan 18;132(2):97-104. doi: 10.7326/0003-4819-132-2-200001180-00002. Ann Intern Med. 2000. PMID: 10644288 Clinical Trial.
• A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.

  Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM; Challenge-Rescue Study Group. Storms W, et al. Respir Med. 2004 Nov;98(11):1051-62. doi: 10.1016/j.rmed.2004.05.008. Respir Med. 2004. PMID: 15526805 Clinical Trial.
• Montelukast and zafirlukast in asthma.

  [No authors listed] [No authors listed] Drug Ther Bull. 1998 Sep;36(9):65-8. Drug Ther Bull. 1998. PMID: 10194869 Review. No abstract available.
• Leukotriene-receptor antagonists.

  Lipworth BJ. Lipworth BJ. Lancet. 1999 Jan 2;353(9146):57-62. doi: 10.1016/S0140-6736(98)09019-9. Lancet. 1999. PMID: 10023966 Review.